BIOGEN INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 231.6 USD | +0.44% |
|
+2.77% | -10.51% |
| May. 16 | Sector Update: Health Care Stocks Mixed in Late Afternoon Trading | MT |
| May. 16 | Sector Update: Health Care Stocks Ease Thursday Afternoon | MT |
ETFs positioned on Biogen Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.21% | 32 M€ | +1.90% | - | |
| 0.21% | 17 M€ | +6.67% | - | |
| 0.20% | 219 M€ | +17.17% | - | |
| 0.20% | 1,448 M€ | -.--% | - | |
| 0.20% | 1,487 M€ | +9.17% | - | |
| 0.20% | 50 M€ | +11.60% | ||
| 0.20% | 330 M€ | -.--% | ||
| 0.20% | 2 M€ | +14.69% | - | |
| 0.18% | 368 M€ | +22.32% | - | |
| 0.18% | 8 M€ | +7.41% | - | |
| 0.18% | 744 M€ | +9.61% | ||
| 0.18% | 276 M€ | +11.40% | - | |
| 0.18% | 655 M€ | -.--% | - | |
| 0.18% | 273 M€ | -.--% | ||
| 0.18% | 1,174 M€ | +23.54% | ||
| 0.17% | 36 M€ | +22.19% | ||
| 0.17% | 253 M€ | +8.08% | ||
| 0.16% | 26 M€ | +22.41% | - | |
| 0.15% | 2,383 M€ | +14.20% | ||
| 0.14% | 1,848 M€ | +18.39% | - | |
| 0.14% | 559 M€ | +14.30% | ||
| 0.13% | 1 M€ | +0.04% | ||
| 0.12% | 6 M€ | +17.98% | - | |
| 0.12% | 121 M€ | +8.29% | - | |
| 0.12% | 2 M€ | +6.15% | - | |
| 0.12% | 17 M€ | +5.97% | - | |
| 0.12% | 205 M€ | -.--% | ||
| 0.11% | 57 M€ | +22.63% | - | |
| 0.10% | 264 M€ | -.--% | - | |
| 0.10% | 187 M€ | +10.81% | - | |
| 0.10% | 477 M€ | +12.67% |
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
Pharmaceuticals
Calendar
2024-06-20
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
231.6
USD
Average target price
285.9
USD
Spread / Average Target
+23.47%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -10.51% | 33.72B | |
| -3.31% | 89.69B | |
| +3.95% | 41.34B | |
| +60.58% | 26.11B | |
| -20.09% | 14.63B | |
| -8.92% | 12.84B | |
| -11.46% | 11.66B | |
| -43.05% | 11.52B | |
| +5.17% | 8.92B | |
| -8.42% | 8.38B |
- Stock Market
- Equities
- BIIB Stock
- Funds and ETFs Biogen Inc.